Diagnostic tests for autoimmune diseases based on microarray technology
ImmunArray has raised €9.1M across 1 funding round from 1 investor, most recently a Series B round in Jul 2016. Based in Rehovot, Israel; founded 2006; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-07-01 | Series B |
| €9.1M |
| Exigent Capital |
| View deal → |
